
Adolf D. Berhane
Examiner (ID: 2145, Phone: (571)272-2077 , Office: P/2838 )
| Most Active Art Unit | 2838 |
| Art Unit(s) | 2102, 2111, 2722, 2838, 2899 |
| Total Applications | 4100 |
| Issued Applications | 3647 |
| Pending Applications | 180 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8270402
[patent_doc_number] => 08211905
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-07-03
[patent_title] => 'Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties'
[patent_app_type] => utility
[patent_app_number] => 12/423641
[patent_app_country] => US
[patent_app_date] => 2009-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 105
[patent_figures_cnt] => 105
[patent_no_of_words] => 28068
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12423641
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/423641 | Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties | Apr 13, 2009 | Issued |
Array
(
[id] => 5474470
[patent_doc_number] => 20090247636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'AGENT FOR SUPPRESSION OF GASTRIC EMPTYING COMPRISING 4-HYDROXYISOLEUCINE'
[patent_app_type] => utility
[patent_app_number] => 12/422488
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3699
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247636.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422488
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422488 | AGENT FOR SUPPRESSION OF GASTRIC EMPTYING COMPRISING 4-HYDROXYISOLEUCINE | Apr 12, 2009 | Abandoned |
Array
(
[id] => 5558865
[patent_doc_number] => 20090270442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'POLYMORPHS OF HYDROCHLORIDE SALT OF 5-(3-(ETHYLSULFONYL)PHENYL)-3,8-DIMETHYL-N-(1-METHYLPIPERIDIN-4-YL)-9H-PYRIDO[2,3-B]INDOLE-7-CARBOXAMIDE AND METHODS OF USE THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 12/422877
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 33641
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270442.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422877
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422877 | POLYMORPHS OF HYDROCHLORIDE SALT OF 5-(3-(ETHYLSULFONYL)PHENYL)-3,8-DIMETHYL-N-(1-METHYLPIPERIDIN-4-YL)-9H-PYRIDO[2,3-B]INDOLE-7-CARBOXAMIDE AND METHODS OF USE THEREFOR | Apr 12, 2009 | Abandoned |
Array
(
[id] => 5570358
[patent_doc_number] => 20090253736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'AZAINDOLE DERIVATIVES AS CFTR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/422496
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25069
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253736.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422496
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422496 | Azaindole derivatives as CFTR modulators | Apr 12, 2009 | Issued |
Array
(
[id] => 6517853
[patent_doc_number] => 20100261731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate'
[patent_app_type] => utility
[patent_app_number] => 12/422434
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6552
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261731.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422434
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422434 | Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate | Apr 12, 2009 | Abandoned |
Array
(
[id] => 6516965
[patent_doc_number] => 20100261684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction'
[patent_app_type] => utility
[patent_app_number] => 12/386008
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1795
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261684.pdf
[firstpage_image] =>[orig_patent_app_number] => 12386008
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/386008 | Pharmaceutical combination of medication to be used by patients presenting with an acute coronary syndrome so as to stop the process and prevent a myocardial infarction | Apr 12, 2009 | Abandoned |
Array
(
[id] => 6516975
[patent_doc_number] => 20100261686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction'
[patent_app_type] => utility
[patent_app_number] => 12/384881
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1120
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261686.pdf
[firstpage_image] =>[orig_patent_app_number] => 12384881
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/384881 | Pharmaceutical combination for the treatment of pain (acute or chronic), as powerful as a narcotic medication but non narcotic ,therefore very unlikely to create addiction | Apr 9, 2009 | Abandoned |
Array
(
[id] => 5485781
[patent_doc_number] => 20090275546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Diagnostic tests and personalized treatment regimes for cancer stem cells'
[patent_app_type] => utility
[patent_app_number] => 12/386002
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15163
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275546.pdf
[firstpage_image] =>[orig_patent_app_number] => 12386002
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/386002 | Diagnostic tests and personalized treatment regimes for cancer stem cells | Apr 9, 2009 | Abandoned |
Array
(
[id] => 5374754
[patent_doc_number] => 20090312315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'PAI-1 INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/422099
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 232953
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312315.pdf
[firstpage_image] =>[orig_patent_app_number] => 12422099
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422099 | PAI-1 inhibitor | Apr 9, 2009 | Issued |
Array
(
[id] => 5485793
[patent_doc_number] => 20090275558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'SUBSTITUTED SULFONAMIDE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/421230
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55147
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275558.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421230
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421230 | Substituted sulfonamide compounds | Apr 8, 2009 | Issued |
Array
(
[id] => 9216372
[patent_doc_number] => 08629172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-14
[patent_title] => 'Methods and compositions for treating post-operative pain comprising clonidine'
[patent_app_type] => utility
[patent_app_number] => 12/421144
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 20
[patent_no_of_words] => 21509
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12421144
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421144 | Methods and compositions for treating post-operative pain comprising clonidine | Apr 8, 2009 | Issued |
Array
(
[id] => 6547960
[patent_doc_number] => 20100016445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'TRANSDERMAL DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/421471
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11882
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016445.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421471
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421471 | TRANSDERMAL DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER | Apr 8, 2009 | Abandoned |
Array
(
[id] => 5570420
[patent_doc_number] => 20090253798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'COLCHICINE SOLID COMPLEX; METHODS OF MAKING; AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/416990
[patent_app_country] => US
[patent_app_date] => 2009-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6207
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253798.pdf
[firstpage_image] =>[orig_patent_app_number] => 12416990
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/416990 | Colchicine solid complex; methods of making; and methods of use thereof | Apr 1, 2009 | Issued |
Array
(
[id] => 5474387
[patent_doc_number] => 20090247553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity'
[patent_app_type] => utility
[patent_app_number] => 12/411526
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9933
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247553.pdf
[firstpage_image] =>[orig_patent_app_number] => 12411526
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/411526 | Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity | Mar 25, 2009 | Abandoned |
Array
(
[id] => 5474409
[patent_doc_number] => 20090247575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/412029
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16353
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247575.pdf
[firstpage_image] =>[orig_patent_app_number] => 12412029
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/412029 | STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS | Mar 25, 2009 | Abandoned |
Array
(
[id] => 9551604
[patent_doc_number] => 08758648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-24
[patent_title] => 'Stabilizer of color former and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/933569
[patent_app_country] => US
[patent_app_date] => 2009-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11381
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12933569
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933569 | Stabilizer of color former and use thereof | Mar 17, 2009 | Issued |
Array
(
[id] => 9844380
[patent_doc_number] => 08946297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-03
[patent_title] => 'Solid composition for pest control'
[patent_app_type] => utility
[patent_app_number] => 12/919428
[patent_app_country] => US
[patent_app_date] => 2009-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3946
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12919428
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919428 | Solid composition for pest control | Mar 17, 2009 | Issued |
Array
(
[id] => 6136989
[patent_doc_number] => 20110009453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => ' S1P3 RECEPTOR INHIBITORS FOR TREATING INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 12/922629
[patent_app_country] => US
[patent_app_date] => 2009-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7205
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009453.pdf
[firstpage_image] =>[orig_patent_app_number] => 12922629
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/922629 | S1P3 RECEPTOR INHIBITORS FOR TREATING INFLAMMATION | Mar 15, 2009 | Abandoned |
Array
(
[id] => 9761886
[patent_doc_number] => 08846205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Hybrid strategies for reducing leaching of metal biocides from biodegradable substrates'
[patent_app_type] => utility
[patent_app_number] => 12/381460
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15240
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12381460
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/381460 | Hybrid strategies for reducing leaching of metal biocides from biodegradable substrates | Mar 11, 2009 | Issued |
Array
(
[id] => 7687491
[patent_doc_number] => 20090176800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'IN VIVO SCREENING METHOD OF THERAPEUTIC AGENT FOR MEMORY/LEARNING DYSFUNCTIONS BY SCHIZOPHRENIA'
[patent_app_type] => utility
[patent_app_number] => 12/401958
[patent_app_country] => US
[patent_app_date] => 2009-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5983
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176800.pdf
[firstpage_image] =>[orig_patent_app_number] => 12401958
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/401958 | Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone | Mar 10, 2009 | Issued |